Bernd R. Seizinger Aprea Therapeutics, Inc. (APRE) insider trading activity

Bernd R. Seizinger is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 34,730 shares of APRE, which is worth approximately $132,668. The most recent transaction as insider was on Jun 20, 2024, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.7K

3.1% 3M change

31.93% 12M change

Total Value Held $132,668

Bernd R. Seizinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2024	BUY Grant, award, or other acquisition	-	1,045 Added 2.92%	34,730 Common Stock
Mar 13 2024	BUY Open market or private purchase	$50,009 $7.29 p/Share	6,860 Added 16.92%	33,685 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	500 Added 1.83%	26,825 Common Stock
Jun 07 2023	BUY Open market or private purchase	$22,186 $3.68 p/Share	6,029 Added 18.63%	26,325 Common Stock
Jun 06 2023	BUY Open market or private purchase	$14,766 $3.63 p/Share	4,068 Added 16.7%	20,296 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	5,995 Added 1.81%	324,575 Common Stock
May 18 2022	BUY Open market or private purchase	$35,500 $0.71 p/Share	50,000 Added 13.57%	318,580 Common Stock

Jun 30 2021	BUY Grant, award, or other acquisition	-	4,610 Added 1.69%	268,580 Common Stock

Also insider at

APTO

Aptose Biosciences Inc. Healthcare

BRS